Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cytochrome c, testis, pseudogene" (CYCTP) refers to a predicted non-protein-coding pseudogene, not to an expressed, functional molecule. While related functional genes exist (such as cytochrome c, testis-specific, involved in electron transport and apoptosis in germ cells[2][3][5][8]), CYCTP itself is not considered an active gene product, not a receptor, enzyme, or other typical therapeutic target. There are no biological functions, known disease roles, biomarkers, drugs, or safety concerns associated with this pseudogene[4]. CYCTP is a pseudogene and not a receptor, enzyme, transporter, or classic drug target. If your intent is to reference an active protein, you likely mean "cytochrome c, testis" (gene symbol CYCT or CYCTE in some species). That protein is an electron carrier involved in apoptosis and mitochondrial electron transport in the testis and has established molecular, functional, and disease associations[3][5][8]. If you require information on the functional testis-specific cytochrome c (gene: CYCT), please clarify, as the information here strictly applies to the pseudogene as described in the query[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c, testis, pseudogene (CYCTP).